Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Coronavirus

The coronavirus pandemic has aggravated and increased the cases of mental health disorders in certain population groups. | Picture by Tumisu from Needpix.
29.06.2020

Two projects to study the impact of COVID-19 on mental health

26.06.2020

The PRBB choir and orchestra, rehearsals during lockdown

We know that animals support people in difficult times, but this benefit has never been measured in a context where the whole population has been exposed to the same problem, on the scale of the COVID-19 epidemic. | Picture by Bruno Cervera from Unsplash.
23.06.2020

Companion animals have been key for emotional support during lockdown

22.06.2020

How to be a researcher and a mum in times of Covid-19

Nearly half of the parets believe the physical and emotional health, as well as the quality of life of children will be affected after lockdown.
21.06.2020

Lockdown has affected the health of children in Spain

The speed with which research results about the coronavirus are going from bench to publication is like nothing we've ever seen before. But it has risks.
01.06.2020

The coronavirus that accelerated science like nothing before

Volunteers from the CRG are coming in everyday to the PRBB to run tests on the coronavirus.Volunteers from the CRG are coming in everyday to the PRBB to run tests on the coronavirus.
25.05.2020

“You are never prepared for this” – an opinion article on the COVID-19 testing experience

The last "IMIM Seminars At Home" presented two of the Covid19 projects taking place at the IMIM. One focuses on drug development, the other relies on the immune response.
22.05.2020

Drugs and antibodies: the strategies of two IMIM groups to block SARS-CoV-2

Ivermectin was recently shown to inhibit the replication of SARS-CoV-2 in vitro at very high doses, but this effect has not yet been studied in vivo. The new study will investigate this question in a randomised trial. | Picture by ISGlobal.
21.05.2020

New study to assess the efficacy of ivermectin against COVID-19

21.05.2020

Re-opening the labs

Untrained staff performing the test will get an unequivocal result from the instrument. | Picture by the UPF.
15.05.2020

InstaCOVID19: UPF develops rapid diagnostic tests for SARS-CoV-2

Edgar Garriga, a PhD student at the CRG, is one of the coronamakers who are voluntarily producing material for health care workers.
14.05.2020

Coronamakers and their 3D printers supply sanitary material to fight COVID-19

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2025 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy
Necessary Always Enabled

Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

*Required field

Field is not valid
You have to authorize data treatment

At any time, you can exercise the rights of access, rectification, opposition, portability, limitation to treatment and deletion of the data subject to treatment by clicking on the links "Update data" and "Unsubscribe", sending a letter indicating the right exercised to the postal address indicated at the bottom or to the following email address ellipse@prbb.org